LIVIVO - Search results -

Search results

Result 1 - 10 of total 374

Search options

Article ; Online ; Conference proceedings: Therapeutic tools in pancreatic cancer.

Hoimes, Christopher J / Strimpakos, Alexios S / Saif, Muhammad Wasif

2009 Volume 10, Issue 2, Page(s) 118–122

Abstract: ... with the prognostic and therapeutic tools available are important to make a worthy impact on a patient's course ... outcome of patients with ascites (Abstract #220). Validated clinical tools that can assist in managing ... Pancreatic cancer is the fourth leading cause of cancer death in the United States and has a lower ...

Abstract	Pancreatic cancer is the fourth leading cause of cancer death in the United States and has a lower survival rate than other digestive tract tumors. It remains a therapeutic challenge with limited active agents. Honing our current understanding of markers of toxicity and response, and individualizing treatment with the prognostic and therapeutic tools available are important to make a worthy impact on a patient's course. The authors summarize selected abstracts from the ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, January 15-17, 2009. The Symposium featured pancreatic cancer in 84 research abstracts, of which, seven are reviewed that focus on markers of toxicity: cytidine deaminase (Abstract #151) and haptogloin (Abstract #167) as markers of gemcitabine toxicity; markers of response: use of PET scan for prognosis (Abstract #157), and correlations with CA 19-9 to post-chemo-radiation resectability (Abstract #215) and time to progression (Abstract #160); and individualized applications: characterizing the phenotypic similarities between a patient tumor and the direct xenograft (Abstract #154) and a report about the poor outcome of patients with ascites (Abstract #220). Validated clinical tools that can assist in managing patients through the narrow therapeutic window are needed.
MeSH term(s)	Biomarkers, Tumor/blood ; CA-19-9 Antigen/blood ; Combined Modality Therapy ; Deoxycytidine/adverse effects ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Haptoglobins/analysis ; Humans ; Pancreas/diagnostic imaging ; Pancreatic Neoplasms/blood ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/therapy ; Positron-Emission Tomography ; Prognosis ; Sensitivity and Specificity
Chemical Substances	Biomarkers, Tumor ; CA-19-9 Antigen ; Haptoglobins ; Deoxycytidine (0W860991D6) ; gemcitabine (B76N6SBZ8R)
Language	English
Publishing date	2009-03-09
Publishing country	Italy
Document type	Congresses
ZDB-ID	2039637-5
ISSN	1590-8577 ; 1590-8577
ISSN (online)	1590-8577
ISSN	1590-8577
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Therapeutic Tools in Pancreatic Cancer

Christopher J Hoimes / Muhammad Wasif Sai / Alexios S Strimpakos

JOP Journal of the Pancreas, Vol 10, Iss 2, Pp 118-

2009 Volume 122

Abstract: ... with the prognostic and therapeutic tools available are important to make a worthy impact on a patient’s course ... of patients with ascites (Abstract #220). Validated clinical tools that can assist in managing patients ... Pancreatic cancer is the fourth leading cause of cancer death in the United States and has a lower ...

Abstract	Pancreatic cancer is the fourth leading cause of cancer death in the United States and has a lower survival rate than other digestive tract tumors. It remains a therapeutic challenge with limited active agents. Honing our current understanding of markers of toxicity and response, and individualizing treatment with the prognostic and therapeutic tools available are important to make a worthy impact on a patient’s course. The authors summarize selected abstracts from the ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, January 15-17, 2009. The Symposium featured pancreatic cancer in 84 research abstracts, of which, seven are reviewed that focus on markers of toxicity: cytidine deaminase (Abstract #151) and haptogloin (Abstract #167) as markers of gemcitabine toxicity; markers of response: use of PET scan for prognosis (Abstract #157), and correlations with CA 19-9 to postchemo-radiation resectability (Abstract #215) and time to progression (Abstract #160); and individualized applications: characterizing the phenotypic similarities between a patient tumor and the direct xenograft (Abstract #154) and a report about the poor outcome of patients with ascites (Abstract #220). Validated clinical tools that can assist in managing patients through the narrow therapeutic window are needed.
Keywords	Ascites ; CA-19-9 Antigen ; gemcitabine ; Cytidine Deaminase ; Haptoglobins ; Pancreatic Neoplasms ; Positron- Emission Tomography ; Xenograft Model Antitumor Assays ; Medicine ; R ; Internal medicine ; RC31-1245 ; Specialties of internal medicine ; RC581-951 ; Diseases of the digestive system. Gastroenterology ; RC799-869
Subject code	610
Publishing date	2009-03-01T00:00:00Z
Publisher	E S Burioni Ricerche Bibliografiche
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.

Shi, Wenjie / Wartmann, Thomas / Accuffi, Sara / Al-Madhi, Sara / Perrakis, Aristotelis / Kahlert, Christoph / Link, Alexander / Venerito, Marino / Keitel-Anselmino, Verena / Bruns, Christiane / Croner, Roland S / Zhao, Yue / Kahlert, Ulf D

British journal of cancer

2023 Volume 130, Issue 1, Page(s) 125–134

Abstract: ... for pancreatic cancer diagnosis and disease staging and might help monitor therapy success. ... Introduction: Pancreatic cancer is a highly aggressive cancer, and early diagnosis significantly ... to implement machine-learning algorithms to aid in early pancreatic cancer diagnosis based on minimally ...

Abstract	Introduction: Pancreatic cancer is a highly aggressive cancer, and early diagnosis significantly improves patient prognosis due to the early implementation of curative-intent surgery. Our study aimed to implement machine-learning algorithms to aid in early pancreatic cancer diagnosis based on minimally invasive liquid biopsies. Materials and methods: The analysis data were derived from nine public pancreatic cancer miRNA datasets and two sequencing datasets from 26 pancreatic cancer patients treated in our medical center, featuring small RNAseq data for patient-matched tumor and non-tumor samples and serum. Upon batch-effect removal, systematic analyses for differences between paired tissue and serum samples were performed. The robust rank aggregation (RRA) algorithm was used to reveal feature markers that were co-expressed by both sample types. The repeatability and real-world significance of the enriched markers were then determined by validating their expression in our patients' serum. The top candidate markers were used to assess the accuracy of predicting pancreatic cancer through four machine learning methods. Notably, these markers were also applied for the identification of pancreatic cancer and pancreatitis. Finally, we explored the clinical prognostic value, candidate targets and predict possible regulatory cell biology mechanisms involved. Results: Our multicenter analysis identified hsa-miR-1246, hsa-miR-205-5p, and hsa-miR-191-5p as promising candidate serum biomarkers to identify pancreatic cancer. In the test dataset, the accuracy values of the prediction model applied via four methods were 94.4%, 84.9%, 82.3%, and 83.3%, respectively. In the real-world study, the accuracy values of this miRNA signatures were 82.3%, 83.5%, 79.0%, and 82.2. Moreover, elevated levels of these miRNAs were significant indicators of advanced disease stage and allowed the discrimination of pancreatitis from pancreatic cancer with an accuracy rate of 91.5%. Elevated expression of hsa-miR-205-5p, a previously undescribed blood marker for pancreatic cancer, is associated with negative clinical outcomes in patients. Conclusion: A panel of three miRNAs was developed with satisfactory statistical and computational performance in real-world data. Circulating hsa-miRNA 205-5p serum levels serve as a minimally invasive, early detection tool for pancreatic cancer diagnosis and disease staging and might help monitor therapy success.
MeSH term(s)	Humans ; Early Detection of Cancer ; MicroRNAs/metabolism ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/genetics ; Liquid Biopsy ; Pancreatitis
Chemical Substances	MicroRNAs
Language	English
Publishing date	2023-11-10
Publishing country	England
Document type	Multicenter Study ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	80075-2
ISSN	1532-1827 ; 0007-0920
ISSN (online)	1532-1827
ISSN	0007-0920
DOI	10.1038/s41416-023-02488-4
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Uh III Zs.142: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: 3d tissue models as tools for radiotherapy screening for pancreatic cancer.

Wishart, Gabrielle / Gupta, Priyanka / Schettino, Giuseppe / Nisbet, Andrew / Velliou, Eirini

The British journal of radiology

2021 Volume 94, Issue 1120, Page(s) 20201397

Abstract: The efficiency of radiotherapy treatment regimes varies from tumour to tumour and from patient ...

Abstract	The efficiency of radiotherapy treatment regimes varies from tumour to tumour and from patient to patient but it is generally highly influenced by the tumour microenvironment (TME). The TME can be described as a heterogeneous composition of biological, biophysical, biomechanical and biochemical milieus that influence the tumour survival and its' response to treatment. Preclinical research faces challenges in the replication of these
MeSH term(s)	Humans ; Models, Biological ; Pancreatic Neoplasms/radiotherapy ; Radiotherapy Planning, Computer-Assisted/methods
Language	English
Publishing date	2021-03-08
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	2982-8
ISSN	1748-880X ; 0007-1285
ISSN (online)	1748-880X
ISSN	0007-1285
DOI	10.1259/bjr.20201397
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Ue I Zs.11: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?

Tarasiuk, Aleksandra / Mackiewicz, Tomasz / Małecka-Panas, Ewa / Fichna, Jakub

Cancer biology & therapy

2021 Volume 22, Issue 5-6, Page(s) 347–356

Abstract: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies, with poor prognosis ...

Abstract	Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies, with poor prognosis resulting mostly from late diagnosis. Surgery remains the most effective treatment and early detection significantly increases the overall survival. Biomarkers used for diagnosis and to monitor the response to treatment, such as carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA), are not adequate as early detection markers of PDAC, partly due to low sensitivity/specificity. Therefore, new biomarkers for PDAC are critically needed. This review aims at recent advancements in the identification and characterization of new biomarkers, microRNAs, which might prove useful in the early detection of PDAC.
MeSH term(s)	Biomarkers, Tumor/genetics ; Carcinoma, Pancreatic Ductal/diagnosis ; Carcinoma, Pancreatic Ductal/genetics ; Carcinoma, Pancreatic Ductal/therapy ; Early Detection of Cancer ; Humans ; MicroRNAs/genetics ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/therapy
Chemical Substances	Biomarkers, Tumor ; MicroRNAs
Language	English
Publishing date	2021-07-05
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't ; Review
ZDB-ID	2146305-0
ISSN	1555-8576 ; 1538-4047
ISSN (online)	1555-8576
ISSN	1538-4047
DOI	10.1080/15384047.2021.1941584
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5887: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer.

Qadir, Muhammad Imran / Faheem, Arooj

Critical reviews in eukaryotic gene expression

2017 Volume 27, Issue 3, Page(s) 197–204

Abstract: ... a significant role in pancreatic cancer regulation. miRNAs are classified as oncomiRs (tumor inducers) and tumor ... Pancreatic ductal adenocarcinoma (PDAC) is fatal disease and one of the major causes of death ... among cancer patients. Diagnosis of PDAC during the early stages of cancer using ultrasounds and blood tests is ...

Abstract	Pancreatic ductal adenocarcinoma (PDAC) is fatal disease and one of the major causes of death among cancer patients. Diagnosis of PDAC during the early stages of cancer using ultrasounds and blood tests is difficult and chemotherapies alone for treating cancers are not very effective. MicroRNAs (miRNAs), small non-coding RNAs that alter the expression of genes in many processes, have been identified to play a significant role in pancreatic cancer regulation. miRNAs are classified as oncomiRs (tumor inducers) and tumor suppressor miRNAs. It has been found that miRNAs are regulated very differently in serum and cells surrounding cancer cells and within cancerous cells. miRNAs regulate cancer cell proliferation, invasion, and apoptosis by being differently up-regulated or downregulated and affecting the expression of genes involved in cancer cell signaling. Therefore, miRNAs can be used as effective diagnostic markers and drug targets for therapy. In this review, we describe the most recent studies performed for understanding molecular mechanisms and gene regulations in PDAC and their utility for diagnosis and therapy.
MeSH term(s)	Adenocarcinoma/blood ; Adenocarcinoma/genetics ; Adenocarcinoma/therapy ; Apoptosis/genetics ; Biomarkers, Tumor/blood ; Carcinoma, Pancreatic Ductal/blood ; Carcinoma, Pancreatic Ductal/genetics ; Carcinoma, Pancreatic Ductal/therapy ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; MicroRNAs/antagonists & inhibitors ; MicroRNAs/blood ; MicroRNAs/therapeutic use
Chemical Substances	Biomarkers, Tumor ; MicroRNAs
Language	English
Publishing date	2017
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	1071345-1
ISSN	1045-4403
ISSN	1045-4403
DOI	10.1615/CritRevEukaryotGeneExpr.2017019494
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3226: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Understanding exosomes: Part 3-therapeutic + diagnostic potential in dentistry.

Miron, Richard J / Estrin, Nathan E / Sculean, Anton / Zhang, Yufeng

Periodontology 2000

2024 Volume 94, Issue 1, Page(s) 415–482

Abstract: ... pancreatic cancer, periodontitis, peri-implantitis, Sjögren syndrome, and various systemic diseases ... oral squamous cell carcinoma, oropharyngeal cancer detection, orthodontic root resorption ... in regenerative medicine has gained tremendous momentum recently due to their ability to be utilized as therapeutic options ...

Abstract	Exosomes are the smallest subset of extracellular signaling vesicles secreted by most cells with the ability to communicate with other tissues and cell types over long distances. Their use in regenerative medicine has gained tremendous momentum recently due to their ability to be utilized as therapeutic options for a wide array of various diseases. Over 5000 publications are currently being published on this topic yearly, many of which in the dental space. This extensive review article is the first scoping review aimed at summarizing all therapeutic uses of exosomes in regenerative dentistry. A total of 944 articles were identified as using exosomes in the dental field for either their regenerative/therapeutic potential or for diagnostic purposes derived from the oral cavity. In total, 113 research articles were selected for their regenerative potential (102 in vitro, 60 in vivo, 50 studies included both). Therapeutic exosomes were most commonly derived from dental pulps, periodontal ligament cells, gingival fibroblasts, stem cells from exfoliated deciduous teeth, and the apical papilla which have all been shown to facilitate the regenerative potential of a number of tissues including bone, cementum, the periodontal ligament, nerves, aid in orthodontic tooth movement, and relieve temporomandibular joint disorders, among others. Results demonstrate that the use of exosomes led to positive outcomes in 100% of studies. In the bone field, exosomes were found to perform equally as well or better than rhBMP2 while significantly reducing inflammation. Periodontitis animal models were treated with simple gingival injections of exosomes and benefits were even observed when the exosomes were administered intravenously. Exosomes are much more stable than growth factors and were shown to be far more resistant against degradation by periodontal pathogens found routinely in a periodontitis environment. Comparative studies in the field of periodontal regeneration found better outcomes for exosomes even when compared to their native parent stem cells. In total 47 diagnostic studies revealed a role for salivary/crevicular fluid exosomes for the diagnosis of birth defects, cardiovascular disease, diabetes, gingival recession detection, gingivitis, irritable bowel syndrome, neurodegenerative disease, oral lichen planus, oral squamous cell carcinoma, oropharyngeal cancer detection, orthodontic root resorption, pancreatic cancer, periodontitis, peri-implantitis, Sjögren syndrome, and various systemic diseases. Hence, we characterize the exosomes as possessing "remarkable" potential, serving as a valuable tool for clinicians with significant advantages.
MeSH term(s)	Exosomes ; Humans ; Regenerative Medicine ; Dentistry ; Regeneration/physiology ; Animals
Language	English
Publishing date	2024-03-28
Publishing country	Denmark
Document type	Journal Article ; Review
ZDB-ID	1200504-6
ISSN	1600-0757 ; 0906-6713
ISSN (online)	1600-0757
ISSN	0906-6713
DOI	10.1111/prd.12557
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 4046: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer.

Tesei, Anna / Cortesi, Michela / Pignatta, Sara / Arienti, Chiara / Dondio, Giulio Massimo / Bigogno, Chiara / Malacrida, Alessio / Miloso, Mariarosaria / Meregalli, Cristina / Chiorazzi, Alessia / Carozzi, Valentina / Cavaletti, Guido / Rui, Marta / Marra, Annamaria / Rossi, Daniela / Collina, Simona

Frontiers in pharmacology

2019 Volume 10, Page(s) 490

Abstract: Introduction: ...

Abstract	Introduction:
Language	English
Publishing date	2019-05-14
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2587355-6
ISSN	1663-9812
ISSN	1663-9812
DOI	10.3389/fphar.2019.00490
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Role of Therapeutic Endoscopic Ultrasound in Management of Pancreatic Cancer: An Endoscopic Oncologist Perspective.

Dahiya, Dushyant Singh / Chandan, Saurabh / Ali, Hassam / Pinnam, Bhanu Siva Mohan / Gangwani, Manesh Kumar / Al Bunni, Hashem / Canakis, Andrew / Gopakumar, Harishankar / Vohra, Ishaan / Bapaye, Jay / Al-Haddad, Mohammad / Sharma, Neil R

Cancers

2023 Volume 15, Issue 12

Abstract: ... EUS) is an indispensable tool for the diagnosis and staging of pancreatic cancer. In the modern era ... of therapeutic interventions. In the context of pancreatic cancer where therapies are limited due to the advanced ... of EUS for pancreatic cancer, namely EUS-guided Fine Needle Injections, EUS-guided Radiotherapy, and EUS ...

Abstract	Pancreatic cancer is a highly lethal disease with an aggressive clinical course. Patients with pancreatic cancer are usually asymptomatic until significant progression of their disease. Additionally, there are no effective screening guidelines for pancreatic cancer in the general population. This leads to a delay in diagnosis and treatment, resulting in poor clinical outcomes and low survival rates. Endoscopic Ultrasound (EUS) is an indispensable tool for the diagnosis and staging of pancreatic cancer. In the modern era, with exponential advancements in technology and device innovation, EUS is also being increasingly used in a variety of therapeutic interventions. In the context of pancreatic cancer where therapies are limited due to the advanced stage of the disease at diagnosis, EUS-guided interventions offer new and innovative options. Moreover, due to their minimally invasive nature and ability to provide real-time images for tumor localization and therapy, they are associated with fewer complication rates compared to conventional open and laparoscopic approaches. In this article, we detail the most current and important therapeutic applications of EUS for pancreatic cancer, namely EUS-guided Fine Needle Injections, EUS-guided Radiotherapy, and EUS-guided Ablations. Furthermore, we also discuss the feasibility and safety profile of each intervention in patients with pancreatic cancer to provide gastrointestinal medical oncologists, radiation and surgical oncologists, and therapeutic endoscopists with valuable information to facilitate patient discussions and aid in the complex decision-making process.
Language	English
Publishing date	2023-06-18
Publishing country	Switzerland
Document type	Journal Article ; Review
ZDB-ID	2527080-1
ISSN	2072-6694
ISSN	2072-6694
DOI	10.3390/cancers15123235
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Extending the boundaries of cancer therapeutic complexity with literature text mining.

Niezni, Danna / Taub-Tabib, Hillel / Harris, Yuval / Sason, Hagit / Amrusi, Yakir / Meron-Azagury, Dana / Avrashami, Maytal / Launer-Wachs, Shaked / Borchardt, Jon / Kusold, M / Tiktinsky, Aryeh / Hope, Tom / Goldberg, Yoav / Shamay, Yosi

Artificial intelligence in medicine

2023 Volume 145, Page(s) 102681

Abstract: Drug combination therapy is a main pillar of cancer therapy. As the number of possible drug ... in cancer treatments. Our primary objectives were: (1) Characterize the existing limitations in combination ... to combinatorial explosion. In this paper, we propose a text mining (TM) based tool and workflow for rapid ...

Abstract	Drug combination therapy is a main pillar of cancer therapy. As the number of possible drug candidates for combinations grows, the development of optimal high complexity combination therapies (involving 4 or more drugs per treatment) such as RCHOP-I and FOLFIRINOX becomes increasingly challenging due to combinatorial explosion. In this paper, we propose a text mining (TM) based tool and workflow for rapid generation of high complexity combination treatments (HCCT) in order to extend the boundaries of complexity in cancer treatments. Our primary objectives were: (1) Characterize the existing limitations in combination therapy; (2) Develop and introduce the Plan Builder (PB) to utilize existing literature for drug combination effectively; (3) Evaluate PB's potential in accelerating the development of HCCT plans. Our results demonstrate that researchers and experts using PB are able to create HCCT plans at much greater speed and quality compared to conventional methods. By releasing PB, we hope to enable more researchers to engage with HCCT planning and demonstrate its clinical efficacy.
MeSH term(s)	Humans ; Antineoplastic Combined Chemotherapy Protocols ; Pancreatic Neoplasms ; Drug Combinations ; Data Mining/methods
Chemical Substances	Drug Combinations
Language	English
Publishing date	2023-10-11
Publishing country	Netherlands
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	645179-2
ISSN	1873-2860 ; 0933-3657
ISSN (online)	1873-2860
ISSN	0933-3657
DOI	10.1016/j.artmed.2023.102681
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 2547: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito